BioPharm America is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Key Sessions

Christine Brennan

Trends in corporate VC investment

MRL Ventures Fund

Patrick Tricoli

Across land and sea: International investment

Nanobiotix USA

Sep 12
Show Filter
7:30am - 8:30am 60 mins
Continental breakfast
7:30am - 5:00pm 570 mins
Main Agenda
Registration // Open all day
8:00am - 6:00pm 600 mins
One-to-one Meetings
One-to-one Meetings
9:30am - 10:15am 45 mins
Therapeutic Spotlight
Advanced therapies: New technologies, new partnering models

In the evolving field of advanced therapies, collaborations with different stakeholders are key to bringing new therapies to market. Biopharmacos, academia, manufacturers, and others are learning to leverage each other’s strengths to create greater opportunities to bring science from bench to bedside.

10:30am - 11:30am 60 mins
Company Presentations
Company Presentations
11:45am - 12:30pm 45 mins
Business and Strategy
Dealmaking strategies: The subtlety of negotiation

The process of dealmaking is never straightforward, but paying attention to the subtleties of negotiation can play an important part in success. The soft factors that influence the final deal can involve internal financial and legal considerations, corporate culture differences, and negotiation processes and structures.  Mastering the intricacies of these underlying factors of negotiation success can mean not only getting the deal done but also determine the success or failure of its implementation. This session will examine the soft factors that impact negotiations and strategies for managing them.

2:30pm - 3:30pm 60 mins
Company Presentations
Company Presentations
3:45pm - 4:30pm 45 mins
Business and Strategy
Across land and sea: International investment
  • Panelist Patrick Tricoli - CEO, Nanobiotix USA

Expanding boundaries and cross-border collaborations are necessary for companies looking to gain market share, access resources, and build capabilities. The influx of companies establishing a presence in the US matches the appetite of companies seeking opportunities in EU and Asia. Executives share their strategies for cultivating a global business and describe new business models for growth.

Showing of Streams